Given that many of the phenotypic effects of AR are pro-tumorigenic and pro-tumor progression, much remains to be discovered regarding mechanisms by which AR negative TNBCs or QNBCs generally have poorer prognoses than AR-positive TNBCs. The gene discussed is AR; the disease is neoplasm.